Contravisory Investment Management, Inc. Danaher Corp Transaction History

Contravisory Investment Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$237.11 - $299.66 $305,397 - $385,962	-1,288 Closed	0 $0
Q1 2022 Apr 08, 2022	SELL	$257.27 - $315.76 $57,371 - $70,414	-223 Reduced 14.76%	1,288 $378,000
Q4 2021 Jan 12, 2022	BUY	$292.08 - $329.01 $61,044 - $68,763	209 Added 16.05%	1,511 $497,000
Q2 2021 Jul 14, 2021	SELL	$225.08 - $271.69 $9,003 - $10,867	-40 Reduced 2.98%	1,302 $349,000
Q1 2021 Apr 14, 2021	SELL	$212.38 - $245.9 $6,159 - $7,131	-29 Reduced 2.12%	1,342 $302,000
Q4 2020 Jan 13, 2021	BUY	$212.5 - $245.46 $4,887 - $5,645	23 Added 1.71%	1,371 $305,000
Q2 2020 Jul 09, 2020	BUY	$128.7 - $176.83 $69,240 - $95,134	538 Added 66.42%	1,348 $236,000
Q1 2020 Apr 09, 2020	BUY	$121.39 - $169.05 $20,636 - $28,738	170 Added 26.56%	810 $112,000
Q4 2019 Jan 09, 2020	BUY	$133.47 - $153.48 $10,277 - $11,817	77 Added 13.68%	640 $98,000
Q3 2019 Oct 07, 2019	BUY	$135.4 - $146.47 $11,238 - $12,157	83 Added 17.29%	563 $81,000
Q2 2019 Jul 09, 2019	BUY	$124.88 - $143.73 $59,942 - $68,990	480 New	480 $69,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.